Annual Operating Profit:
$551.48M+$213.90M(+63.36%)Summary
- As of today, HALO annual operating income is $551.48 million, with the most recent change of +$213.90 million (+63.36%) on December 31, 2024.
- During the last 3 years, HALO annual operating profit has risen by +$275.57 million (+99.88%).
- HALO annual operating profit is now at all-time high.
Performance
HALO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Profit:
$202.44M+$60.91M(+43.03%)Summary
- As of today, HALO quarterly operating income is $202.44 million, with the most recent change of +$60.91 million (+43.03%) on June 30, 2025.
- Over the past year, HALO quarterly operating profit has increased by +$85.21 million (+72.68%).
- HALO quarterly operating profit is now at all-time high.
Performance
HALO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Operating Profit:
$682.67M+$85.21M(+14.26%)Summary
- As of today, HALO TTM operating income is $682.67 million, with the most recent change of +$85.21 million (+14.26%) on June 30, 2025.
- Over the past year, HALO TTM operating profit has increased by +$280.58 million (+69.78%).
- HALO TTM operating profit is now at all-time high.
Performance
HALO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
HALO Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +63.4% | +72.7% | +69.8% |
3Y3 Years | +99.9% | +494.4% | +182.3% |
5Y5 Years | +915.7% | +585.0% | +1874.8% |
HALO Operating Profit Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | at high | +106.1% | at high | +276.3% | at high | +177.9% |
5Y | 5-Year | at high | +915.7% | at high | +494.4% | at high | +1874.8% |
All-Time | All-Time | at high | +762.8% | at high | +731.4% | at high | +794.3% |
HALO Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $202.44M(+43.0%) | $682.67M(+14.3%) |
Mar 2025 | - | $141.53M(-19.4%) | $597.47M(+8.3%) |
Dec 2024 | $551.48M(+63.4%) | $175.50M(+7.5%) | $551.48M(+15.6%) |
Sep 2024 | - | $163.20M(+39.2%) | $477.01M(+18.6%) |
Jun 2024 | - | $117.23M(+22.7%) | $402.09M(+6.0%) |
Mar 2024 | - | $95.54M(-5.4%) | $379.31M(+12.4%) |
Dec 2023 | $337.57M(+26.2%) | $101.03M(+14.4%) | $337.57M(+8.5%) |
Sep 2023 | - | $88.28M(-6.5%) | $311.05M(+1.6%) |
Jun 2023 | - | $94.46M(+75.6%) | $306.06M(+24.6%) |
Mar 2023 | - | $53.80M(-27.8%) | $245.66M(-8.2%) |
Dec 2022 | $267.53M(-3.0%) | $74.51M(-10.5%) | $267.53M(+7.2%) |
Sep 2022 | - | $83.29M(+144.5%) | $249.56M(+3.2%) |
Jun 2022 | - | $34.06M(-55.0%) | $241.85M(-19.6%) |
Mar 2022 | - | $75.67M(+33.8%) | $300.84M(+9.0%) |
Dec 2021 | $275.90M(+91.3%) | $56.53M(-25.2%) | $275.90M(-7.1%) |
Sep 2021 | - | $75.59M(-18.8%) | $296.99M(+13.5%) |
Jun 2021 | - | $93.05M(+83.4%) | $261.70M(+32.0%) |
Mar 2021 | - | $50.73M(-34.6%) | $198.21M(+37.4%) |
Dec 2020 | $144.25M(+313.4%) | $77.62M(+92.6%) | $144.25M(+317.3%) |
Sep 2020 | - | $40.30M(+36.4%) | $34.57M(+214.2%) |
Jun 2020 | - | $29.55M(+1017.0%) | -$30.27M(+59.0%) |
Mar 2020 | - | -$3.22M(+89.9%) | -$73.80M(-9.2%) |
Dec 2019 | -$67.61M(+2.5%) | -$32.06M(-30.7%) | -$67.61M(-89.8%) |
Sep 2019 | - | -$24.54M(-75.6%) | -$35.62M(+2.6%) |
Jun 2019 | - | -$13.98M(-571.2%) | -$36.56M(+14.3%) |
Mar 2019 | - | $2.97M(+4277.5%) | -$42.65M(+38.5%) |
Dec 2018 | -$69.33M(-185.6%) | -$71.00K(+99.7%) | -$69.33M(-222.3%) |
Sep 2018 | - | -$25.47M(-26.9%) | $56.67M(-37.2%) |
Jun 2018 | - | -$20.07M(+15.3%) | $90.22M(+6.4%) |
Mar 2018 | - | -$23.71M(-118.8%) | $84.82M(+4.7%) |
Dec 2017 | $81.00M(+197.3%) | $125.93M(+1459.1%) | $81.00M(+220.0%) |
Sep 2017 | - | $8.08M(+131.7%) | -$67.50M(+31.3%) |
Jun 2017 | - | -$25.48M(+7.4%) | -$98.32M(-4.0%) |
Mar 2017 | - | -$27.53M(-21.9%) | -$94.57M(-13.6%) |
Dec 2016 | -$83.21M(-203.1%) | -$22.57M(+0.7%) | -$83.21M(-50.8%) |
Sep 2016 | - | -$22.74M(-4.7%) | -$55.17M(+0.9%) |
Jun 2016 | - | -$21.72M(-34.3%) | -$55.66M(-87.4%) |
Mar 2016 | - | -$16.17M(-395.9%) | -$29.71M(-8.2%) |
Dec 2015 | -$27.45M(+56.5%) | $5.46M(+123.5%) | -$27.45M(+25.3%) |
Sep 2015 | - | -$23.24M(-649.2%) | -$36.77M(-12.9%) |
Jun 2015 | - | $4.23M(+130.4%) | -$32.56M(+37.1%) |
Mar 2015 | - | -$13.91M(-261.2%) | -$51.73M(+17.9%) |
Dec 2014 | -$63.04M(+21.6%) | -$3.85M(+79.8%) | -$63.04M(+21.7%) |
Sep 2014 | - | -$19.03M(-27.3%) | -$80.51M(-0.7%) |
Jun 2014 | - | -$14.94M(+40.8%) | -$79.98M(+8.2%) |
Mar 2014 | - | -$25.22M(-18.3%) | -$87.16M(-8.4%) |
Dec 2013 | -$80.43M | -$21.32M(-15.3%) | -$80.43M(-26.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2013 | - | -$18.49M(+16.4%) | -$63.52M(+2.4%) |
Jun 2013 | - | -$22.12M(-19.6%) | -$65.05M(-14.2%) |
Mar 2013 | - | -$18.50M(-319.7%) | -$56.98M(-6.3%) |
Dec 2012 | -$53.63M(-170.3%) | -$4.41M(+78.0%) | -$53.63M(+20.7%) |
Sep 2012 | - | -$20.03M(-42.6%) | -$67.65M(-59.3%) |
Jun 2012 | - | -$14.05M(+7.2%) | -$42.46M(-67.7%) |
Mar 2012 | - | -$15.14M(+17.8%) | -$25.32M(-27.6%) |
Dec 2011 | -$19.84M(+63.4%) | -$18.43M(-457.6%) | -$19.84M(-2.8%) |
Sep 2011 | - | $5.15M(+66.4%) | -$19.29M(+47.7%) |
Jun 2011 | - | $3.10M(+132.0%) | -$36.88M(+29.3%) |
Mar 2011 | - | -$9.66M(+46.0%) | -$52.13M(+3.9%) |
Dec 2010 | -$54.26M(+7.2%) | -$17.88M(-43.8%) | -$54.26M(-10.6%) |
Sep 2010 | - | -$12.43M(-2.3%) | -$49.05M(+3.0%) |
Jun 2010 | - | -$12.15M(-3.1%) | -$50.56M(+8.9%) |
Mar 2010 | - | -$11.79M(+7.0%) | -$55.49M(+5.1%) |
Dec 2009 | -$58.46M(-15.9%) | -$12.68M(+9.1%) | -$58.46M(+6.9%) |
Sep 2009 | - | -$13.94M(+18.4%) | -$62.81M(-4.6%) |
Jun 2009 | - | -$17.08M(-15.8%) | -$60.07M(-10.5%) |
Mar 2009 | - | -$14.76M(+13.3%) | -$54.36M(-7.8%) |
Dec 2008 | -$50.43M(-79.2%) | -$17.03M(-52.0%) | -$50.43M(-16.4%) |
Sep 2008 | - | -$11.20M(+1.5%) | -$43.34M(-7.1%) |
Jun 2008 | - | -$11.37M(-5.0%) | -$40.45M(-15.9%) |
Mar 2008 | - | -$10.83M(-9.1%) | -$34.90M(-24.0%) |
Dec 2007 | -$28.15M(-80.6%) | -$9.93M(-19.5%) | -$28.15M(-23.0%) |
Sep 2007 | - | -$8.31M(-42.5%) | -$22.89M(-24.4%) |
Jun 2007 | - | -$5.83M(-42.9%) | -$18.41M(-15.1%) |
Mar 2007 | - | -$4.08M(+12.6%) | -$15.99M(-2.6%) |
Dec 2006 | -$15.58M(-14.9%) | -$4.67M(-22.0%) | -$15.58M(-7.5%) |
Sep 2006 | - | -$3.83M(-12.0%) | -$14.49M(-0.4%) |
Jun 2006 | - | -$3.42M(+7.0%) | -$14.43M(-3.4%) |
Mar 2006 | - | -$3.67M(-2.6%) | -$13.96M(-3.0%) |
Dec 2005 | -$13.56M(-49.2%) | -$3.58M(+5.0%) | -$13.56M(-8.4%) |
Sep 2005 | - | -$3.77M(-27.8%) | -$12.51M(-4.2%) |
Jun 2005 | - | -$2.95M(+9.9%) | -$12.01M(-7.7%) |
Mar 2005 | - | -$3.27M(-29.4%) | -$11.15M(-22.7%) |
Dec 2004 | -$9.09M(>-9900.0%) | -$2.53M(+22.5%) | -$9.09M(-64.4%) |
Sep 2004 | - | -$3.26M(-56.2%) | -$5.53M(-106.8%) |
Jun 2004 | - | -$2.09M(-73.0%) | -$2.67M(-179.5%) |
Mar 2004 | - | -$1.21M(-217.0%) | -$956.20K(>-9900.0%) |
Dec 2003 | $0.00(0.0%) | $1.03M(+352.9%) | $0.00(+100.0%) |
Sep 2003 | - | -$408.20K(-9.5%) | -$1.01M(-64.0%) |
Jun 2003 | - | -$372.90K(-48.3%) | -$618.40K(-134.4%) |
Mar 2003 | - | -$251.40K(-1458.9%) | -$263.80K(>-9900.0%) |
Dec 2002 | $0.00(+100.0%) | $18.50K(+246.8%) | $0.00(+100.0%) |
Sep 2002 | - | -$12.60K(+31.1%) | -$18.50K(-213.6%) |
Jun 2002 | - | -$18.30K(-247.6%) | -$5900.00(-147.6%) |
Mar 2002 | - | $12.40K | $12.40K |
Dec 2001 | -$39.70K | - | - |
FAQ
- What is Halozyme Therapeutics, Inc. annual operating income?
- What is the all-time high annual operating profit for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. annual operating profit year-on-year change?
- What is Halozyme Therapeutics, Inc. quarterly operating income?
- What is the all-time high quarterly operating profit for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. quarterly operating profit year-on-year change?
- What is Halozyme Therapeutics, Inc. TTM operating income?
- What is the all-time high TTM operating profit for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. TTM operating profit year-on-year change?
What is Halozyme Therapeutics, Inc. annual operating income?
The current annual operating profit of HALO is $551.48M
What is the all-time high annual operating profit for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high annual operating income is $551.48M
What is Halozyme Therapeutics, Inc. annual operating profit year-on-year change?
Over the past year, HALO annual operating income has changed by +$213.90M (+63.36%)
What is Halozyme Therapeutics, Inc. quarterly operating income?
The current quarterly operating profit of HALO is $202.44M
What is the all-time high quarterly operating profit for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high quarterly operating income is $202.44M
What is Halozyme Therapeutics, Inc. quarterly operating profit year-on-year change?
Over the past year, HALO quarterly operating income has changed by +$85.21M (+72.68%)
What is Halozyme Therapeutics, Inc. TTM operating income?
The current TTM operating profit of HALO is $682.67M
What is the all-time high TTM operating profit for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high TTM operating income is $682.67M
What is Halozyme Therapeutics, Inc. TTM operating profit year-on-year change?
Over the past year, HALO TTM operating income has changed by +$280.58M (+69.78%)